Contribution in an anthology

Antiparasitic Peptides


Authors listPretzel, J; Mohring, F; Rahlfs, S; Becker, K

Appeared inAdvances in Biochemical Engineering-Biotechnology

Editor listVilcinskas, A

Publication year2013

Pages157-192

JournalAdvances in Biochemical Engineering Biotechnology

ISSN0724-6145

ISBN978-3-642-39862-9

eISBN978-3-642-39863-6

DOI Linkhttps://doi.org/10.1007/10_2013_191

PublisherSpringer Verlag Kg

Title of seriesAdvances in Biochemical Engineering/Biotechnology

Number in series135


Abstract
The most important parasitic diseases, malaria, leishmaniasis, trypanosomiasis, and schistosomiasis, are a great burden to mankind, threatening the life of millions of people worldwide and mostly affecting the poorest. Because drug resistance is increasing and vaccines are rarely available, novel chemotherapeutic compounds are necessary in order to treat these devastating diseases. Insects serve as vectors of many human parasitic diseases and have been shown to express a huge variety of antimicrobial peptides (AMPs). Therefore, research activity on insect-derived AMPs has been increasing in the last 40 years. This chapter summarizes the current state of research on the possible role of AMPs as potential chemotherapeutic compounds against human parasitic diseases.



Authors/Editors




Citation Styles

Harvard Citation stylePretzel, J., Mohring, F., Rahlfs, S. and Becker, K. (2013) Antiparasitic Peptides, in Vilcinskas, A. (ed.) Advances in Biochemical Engineering-Biotechnology. Belrin, Heidelberg: Springer Verlag Kg, pp. 157-192. https://doi.org/10.1007/10_2013_191

APA Citation stylePretzel, J., Mohring, F., Rahlfs, S., & Becker, K. (2013). Antiparasitic Peptides. In Vilcinskas, A. (Ed.), Advances in Biochemical Engineering-Biotechnology (pp. 157-192). Springer Verlag Kg. https://doi.org/10.1007/10_2013_191


Last updated on 2025-21-05 at 15:31